Baal, Having the IND approved by Psychiatric will also be a major event. Cortex should hear more from Neurology over the next month also, since Neurology is still in the process of reviewing the tox data. Concerning when the IND for ADHD will be filed, in his NI update Neuro said - "Now Cortex can complete the IND application to Psychiatry--probably around the end of summer." <<<
I sure wouldn't make that assumption, especially if you are considering sale of your COR holdings to return in a couple of months or so. With these small caps, expect the unexpected, as we have seen with COR.
Market Data 
Markets 
AI
